Pharmaceutical

Cipla sees highest patent filings and grants during Sep...

Cipla saw the highest growth of 199% in patent filings in September and 99% in g...

Sun Pharmaceutical Industries sees highest patent filin...

Sun Pharmaceutical Industries saw the highest growth of 162% in patent filings i...

CSL sees highest patent filings and grants during Augus...

CSL saw the highest growth of 126% in patent filings and 174% in grants in July ...

STAT+: CAR-T, recently used in a lupus patient, helps o...

CAR-T, recently used in a lupus patient, helps other autoimmune patients, too, i...

STAT+: Was CAR-T therapy a bystander or driver of lymph...

The case of an Australian cancer patient treated with CAR-T suggests one way the...

Opinion: STAT readers on diagnostic tests, marijuana re...

STAT Letters to the Editor: “The costs [of diagnostic tests] both monetarily and...

STAT+: Vertex gets a win as Colorado board leaves cysti...

In a win for Vertex Pharmaceuticals, a Colorado state board voted not to place t...

STAT+: Tough road ahead for Bluebird Bio despite FDA ap...

The FDA's approval of two gene therapies sets the stage for intense competition ...

STAT+: Medicare’s advisory committee isn’t sold on big ...

On Thursday, MedPAC concluded that even though doctors’ pay hasn’t kept up with ...

Chronic fatigue syndrome estimated to affect 3.3 millio...

Chronic fatigue syndrome is clearly "is not a rare illness,” said the CDC's Eliz...

STAT+: A Q&A with the CEO of CRISPR Therapeutics on a h...

STAT spoke to the CEO of CRISPR Therapeutics about how the company secured a his...

Opinion: After living with sickle cell disease for 39 y...

What a sickle cell disease patient thinks is the biggest challenge facing a newl...

In historic decision, FDA approves a CRISPR-based medic...

The FDA has approved the world’s first medicine based on CRISPR gene-editing tec...

Morning Rounds: 3D-printed organs, antimicrobial resist...

Understand how science, health policy, and medicine shape the world everyday. Si...

CRISPR is about to make history. Here’s the 5-minute ru...

Want to stay on top of the science and politics driving biotech today? Sign up t...

STAT+: Pharmalittle: Biden pharma patent proposal spurs...

Biden's plan to sidestep certain patents is causing uncertainty over the extent ...